Charles Douglas Blundell
Founder at C4X Discovery Ltd.
Profile
Charles Douglas Blundell is the founder.
He founded C4X Discovery Ltd.
in 2008 and currently holds the title of Director & Chief Scientific Officer.
He also founded C4X Discovery Holdings Plc in 2008 and held the title of Chief Scientific Officer.
Dr. Blundell obtained a doctorate degree from the University of Oxford.
Charles Douglas Blundell active positions
| Companies | Position | Start |
|---|---|---|
C4X Discovery Ltd.
 C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology C4X Discovery Ltd. engages in the discovery and development of medical drugs. It uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom. | Founder | 2009-11-22 |
Former positions of Charles Douglas Blundell
| Companies | Position | End |
|---|---|---|
| C4X DISCOVERY HOLDINGS PLC | Founder | - |
Training of Charles Douglas Blundell
| University of Oxford | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| C4X DISCOVERY HOLDINGS PLC | Health Technology |
| Private companies | 1 |
|---|---|
C4X Discovery Ltd.
C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology C4X Discovery Ltd. engages in the discovery and development of medical drugs. It uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Charles Douglas Blundell
